Thursday, Sep 16, 2021
Outlook.com
Outlook.com

Phase Three Clinical Trial Concludes 77.8 Per Cent Effectiveness Of Covaxin

The report suggests that the vaccine is capable of providing 65.2 percent protection from the lethal Delta Plus strain of Coronavirus and 93.4 per cent protection against the severely symptomatic cases

Phase Three Clinical Trial Concludes 77.8 Per Cent Effectiveness Of Covaxin
Bharat Biotech's report of phase three of clinical trial suggests 77.8 percent overall efficacy of Covaxin | File Photo
Phase Three Clinical Trial Concludes 77.8 Per Cent Effectiveness Of Covaxin
outlookindia.com
2021-07-03T11:41:47+05:30

Bharat Biotech’s third phase of clinical trial emerges with an overall 77.8 percent efficacy of Covaxin. The company officials confirmed on Saturday citing data from the clinical trial report. Peer- reviewing of the data, although, is still awaited.

"We are proud to put India on the global map with scientific conviction, competence and commitment. Covaxin scores 10 world-class publications endorsing Innovation, clinical research, data, safety, efficacy. Thank collaborators & Positive BB teamwork enduring a pandemic (sic)," Bharat Biotech co-founder Suchitra Ella said in a late-night tweet.

The phase three clinical trial report suggests that the vaccine is capable of providing 65.2 percent protection from the lethal Delta Plus strain of Coronavirus.

The efficacy analysis also ensures a whopping 93.4% protection against the severely symptomatic cases. For asymptomatic cases, the figure stands at 63.6 percent though.

Covaxin is an entirely virus inactivated vaccine for protection against SARS- CoV2. Bharat Biotech is the primary manufacturer of the vaccine in collaboration with ICMR and NIV, Pune.

The efficacy analysis procedure of the phase three clinical trial is based on analyzing 130 symptomatic COVID-19 cases across 25 sites in India. The cases were compulsorily reported two weeks after taking the second jab.

Advertisement

Outlook Newsletters

Advertisement

Read More from Outlook

Kohli's Stepping Down As India's T20 Captain Part Of BCCI 'Roadmap'

Kohli's Stepping Down As India's T20 Captain Part Of BCCI 'Roadmap'

Virat Kohli will hand over India's T20 captaincy after the World Cup in October-November. Given his IPL record as skipper, Rohit Sharma is widely tipped to succeed Kohli.

24 New Ministers Sworn In To Gujarat Cabinet, Bhupendra Patel To Hold First Meeting As CM

24 New Ministers Sworn In To Gujarat Cabinet, Bhupendra Patel To Hold First Meeting As CM

Governor Acharya Devvrat administered the oath to 10 cabinet ministers and 14 ministers of state along with five ministers of state with independent charge.

FM Sitharaman Announced Setting Up Of National Asset Reconstruction Company

FM Sitharaman Announced Setting Up Of National Asset Reconstruction Company

Finance Minister Nirmala Sitharaman on September 16 announced that the Cabinet has approved a central government guarantee of up to Rs 30,600 crore to back security receipts to be issued by National Asset Reconstruction Company Limited (NARCL). The guarantee would be valid for a period of five years. Asset reconstruction companies (ARCs) generally buy distressed assets with a 15 per cent cash payment and 85 per cent in security receipts.

Farmer Protests: Haryana Govt Forms Committee To Resolve Highway Blockade Issue

Farmer Protests: Haryana Govt Forms Committee To Resolve Highway Blockade Issue

Haryana government constituted a state-level committee to hold discussions with the farmers’ and farmers’ unions regarding the ongoing blockade of NH-44 by protesting farmers.

Advertisement